Literature DB >> 22471702

Deficiency of interleukin-1 receptor antagonist responsive to anakinra.

Charlotte Schnellbacher1, Giovanna Ciocca, Roxanna Menendez, Ivona Aksentijevich, Raphaela Goldbach-Mansky, Ana M Duarte, Rafael Rivas-Chacon.   

Abstract

We describe a 3-month-old infant who presented to our institution with interleukin (IL)-1 receptor antagonist deficiency (DIRA), which consists of neutrophilic pustular dermatosis, periostitis, aseptic multifocal osteomyelitis, and persistently high acute-phase reactants. Skin findings promptly improved upon initiation of treatment with anakinra (recombinant human IL-1 receptor antagonist), and the bony lesions and systemic inflammation resolved with continued therapy.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22471702      PMCID： PMC3548019          DOI： 10.1111/j.1525-1470.2012.01725.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  5 in total

Review 1.  Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.

Authors:  W P Arend
Journal:  Semin Arthritis Rheum       Date:  2001-04       Impact factor: 5.532

2.  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

Authors:  Ivona Aksentijevich; Seth L Masters; Polly J Ferguson; Paul Dancey; Joost Frenkel; Annet van Royen-Kerkhoff; Ron Laxer; Ulf Tedgård; Edward W Cowen; Tuyet-Hang Pham; Matthew Booty; Jacob D Estes; Netanya G Sandler; Nicole Plass; Deborah L Stone; Maria L Turner; Suvimol Hill; John A Butman; Rayfel Schneider; Paul Babyn; Hatem I El-Shanti; Elena Pope; Karyl Barron; Xinyu Bing; Arian Laurence; Chyi-Chia R Lee; Dawn Chapelle; Gillian I Clarke; Kamal Ohson; Marc Nicholson; Massimo Gadina; Barbara Yang; Benjamin D Korman; Peter K Gregersen; P Martin van Hagen; A Elisabeth Hak; Marjan Huizing; Proton Rahman; Daniel C Douek; Elaine F Remmers; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  Autoinflammatory disease reloaded: a clinical perspective.

Authors:  Daniel L Kastner; Ivona Aksentijevich; Raphaela Goldbach-Mansky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Authors:  Sreelatha Reddy; Shuang Jia; Rhonda Geoffrey; Rachel Lorier; Mariko Suchi; Ulrich Broeckel; Martin J Hessner; James Verbsky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

Review 5.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113
  5 in total
  21 in total

Review 1.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

2.  The inflammasomes in autoinflammatory diseases with skin involvement.

Authors:  Hans-Dietmar Beer; Emmanuel Contassot; Lars E French
Journal:  J Invest Dermatol       Date:  2014-03-06       Impact factor: 8.551

3.  Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist.

Authors:  Megha Garg; Adriana A de Jesus; Dawn Chapelle; Paul Dancey; Ronit Herzog; Rafael Rivas-Chacon; Theresa L Wampler Muskardin; Ann Reed; James C Reynolds; Raphaela Goldbach-Mansky; Gina A Montealegre Sanchez
Journal:  JCI Insight       Date:  2017-08-17

Review 4.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

Review 5.  Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Nurul Amirah Mohd Zaid; Mahendran Sekar; Srinivasa Reddy Bonam; Siew Hua Gan; Pei Teng Lum; M Yasmin Begum; Nur Najihah Izzati Mat Rani; Jaishree Vaijanathappa; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

Review 6.  Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease.

Authors:  Hsu-Wen Tseng; Selwin Gabriel Samuel; Kate Schroder; Jean-Pierre Lévesque; Kylie A Alexander
Journal:  Curr Osteoporos Rep       Date:  2022-05-14       Impact factor: 5.163

Review 7.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

Review 8.  Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.

Authors:  Manisha Sharma; Polly J Ferguson
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

9.  A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset.

Authors:  Ender Altiok; Figen Aksoy; Yıldız Perk; Fulya Taylan; Peter W Kim; Barbaros Ilıkkan; Gülten Turkkani Asal; Raphaela Goldbach-Mansky; Ozden Sanal
Journal:  Clin Immunol       Date:  2012-08-16       Impact factor: 3.969

Review 10.  Autoinflammatory bone diseases.

Authors:  Sara M Stern; Polly J Ferguson
Journal:  Rheum Dis Clin North Am       Date:  2013-08-17       Impact factor: 2.670
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.